The influence of sex on non-motor wearing-off in Parkinson's disease: A WORK-PD post-hoc study.

Anxiety Levodopa Non-motor fluctuations Parkinson’s disease Sex Wearing off

Journal

Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130

Informations de publication

Date de publication:
07 Jun 2024
Historique:
received: 06 03 2024
revised: 13 05 2024
accepted: 02 06 2024
medline: 10 6 2024
pubmed: 10 6 2024
entrez: 9 6 2024
Statut: aheadofprint

Résumé

The wearing-off phenomenon is characterized by the recurrence of motor and non-motor symptoms of Parkinsonism during a period free from levodopa. It is a pivotal aspect marking the end of the pharmacological "honeymoon" period in Parkinson's disease (PD). A growing body of literature is connecting sex with the likelihood of developing fluctuations. We investigated such an association in a post-hoc analysis of the large WORK-PD study. WORK-PD analyzed the usability of the wearing-off questionnaire 19 (WOQ19) in clinical practice and included cross-sectional data on age, disease duration, time on levodopa, Hoehn and Yahr stage, and WOQ19 scores of 532 PD patients. In the present study, we selected patients with an exposure time to levodopa of at least 1 year. A total of 380 patients were included. Women reported a higher number of wearing-off symptoms than men (6.09 ± 3.39 vs 4.96 ± 3.11, p = 0.0006). Sex groups also differed in non-motor symptoms (2 ± 1.9 vs 1.5 ± 1.5, p = 0.021), particularly behavioral wearing-off scores being higher in women (p < 0.001). The latter were primarily featured by anxiety-related phenomena. Finally, there was a significant interaction between behavioral symptoms, sex, and age at onset (df = 2, F = 9.79, p < 0.0001), whereas no such interaction was observed with levodopa exposure and motor impairment, unlike motor symptoms. Women showed a greater propensity than men to experience wearing-off, particularly non-motor fluctuations on the anxiety spectrum. The latter may demonstrate a lesser reliance on dopamine compared to motor symptoms. This observation could be underpinned by biological variances between genders at the neurotransmitter level.

Identifiants

pubmed: 38852765
pii: S0304-3940(24)00228-3
doi: 10.1016/j.neulet.2024.137850
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

137850

Informations de copyright

Copyright © 2024 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Massimo Marano (M)

Unit of Neurology, Neurophysiology, Neurobiology and Psychiatry, Department of Medicine, University Campus Bio-Medico of Rome, Rome, Italy; Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy. Electronic address: m.marano@policlinicocampus.it.

Maria Concetta Altavista (M)

Neurology Unit, San Filippo Neri Hospital, ASL RM1, Rome, Italy.

Emanuele Cassetta (E)

Neurology Unit, San Giovanni Calibita Hospital - Gemelli Isola, IRCCS Fondazione Policlinico Universitario Gemelli, Rome, Italy.

Livia Brusa (L)

Department of Neurology, Sant'Eugenio Hospital, Rome, Italy.

Fabio Viselli (F)

Department of Neurology, San Giovanni Battista, ACISMOM, Rome, Italy.

Alessandro Denaro (A)

Department of Medical and Surgical Sciences and Biotechnologies, "Sapienza" University of Rome, Polo Pontino, Latina, Italy.

Mariacarla Ventriglia (M)

Clinical Research Centre, Ospedale Isola Tiberina - Gemelli Isola, Rome, Italy.

Antonella Peppe (A)

Clinical Neuroscience, IRCCS Fondazione Santa Lucia, Rome, Italy.

Classifications MeSH